Incidence and trend of a metabolic syndrome phenotype among Tehranian adolescents: findings from the Tehran Lipid and Glucose Study, 1998-2001 to 2003-2006.
OBJECTIVE
To assess the incidence and trend of the metabolic syndrome phenotype in adolescents from the Tehran Lipid and Glucose Study during 3.6 years of follow-up.


METHODS
A total of 932 adolescents, aged 10-19 years, who had complete data and returned for reassessment 3.6 years later were investigated.


RESULTS
Prevalence of metabolic syndrome at baseline and after 3.6 years was 7.4 and 6.7%, respectively, based on the Adult Treatment Panel (ATP) III definitions; 3.5 and 8.0%, respectively, based on the International Diabetes Federation (IDF) definitions; 4.1 and 9.4%, respectively, based on the American Heart Association (AHA) definitions; and 13.6 and 13.4%, respectively, based on the National Health and Nutrition Examination Survey (NHANES) definitions. Incidence rates were 5.2% (95% CI 3-6) based on ATP III, 6.8% (5-8) based on IDF, 8.3% (6-10) based on AHA, and 8.8% (6-10) based on NHANES definitions.


CONCLUSIONS
Incidence of metabolic syndrome is high in Tehranian adolescents.
Afkhami-Ardekani
Mohammad
M
Yazd Diabetes Research Center, Shahid Sadoughi University of Medical Science, Yazd, Iran.
Zahedi-Asl
Saleh
S
Rashidi
Maryam
M
Atifah
Mitra
M
Hosseinpanah
Farhad
F
Azizi
Fereidoun
F
D000293:Adolescent; D000328:Adult; D015992:Body Mass Index; D002648:Child; D005260:Female; D006801:Humans; D015994:Incidence; D007492:Iran / Q000453:epidemiology; D016015:Logistic Models; D008297:Male; D024821:Metabolic Syndrome / Q000453:epidemiology*; D055815:Young Adult